Targeted molecular therapies for cancer treatment have shown promise, but also have limitations. In this issue, Heidorn et al. (2010) find that a class of targeted molecular therapies with clinical effectiveness against one melanoma subtype may have adverse clinical effects in another. © 2010 Elsevier Inc. All rights reserved.
CITATION STYLE
Kwong, L. N., & Chin, L. (2010, January 22). The Brothers RAF. Cell. Elsevier B.V. https://doi.org/10.1016/j.cell.2010.01.013
Mendeley helps you to discover research relevant for your work.